Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top…
thinkstockFebruary 5, 2014: Markets opened lower on Wednesday following the report from ADP that nonfarm payrolls had risen less than expected in January. And unlike yesterday, the Japanese yen gathered strength early…
Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to dazzle. But shares traded higher in the premarket session.
thinkstockFebruary 4, 2014: Markets opened higher on Tuesday following a crushing on Monday that saw all three major indexes put up at least a 2% loss on the day. Equities got some…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014. They include Chevron, Gap, Merck, Microsoft and Zynga.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, January 29, 2014. They include American Airlines, Electronic Arts, VMware, Walmart and more.
thinkstockJanuary 28, 2014: Markets opened mixed on Tuesday, with the Nasdaq trailing at the opening bell as shares in Apple sold off following last night’s earnings report. Today’s economic data was also…
Pfizer has managed to handily beat consensus fourth-quarter earnings expectations, at least on the surface. It also offered guidance for 2014 in line with consensus estimates.
Jon C. Ogg Facebook has been listed at a public company for two years, yet it is one of the most widely traded stocks on any U.S. exchange. Others vying for the top spot have…
Pfizer says a new study suggests its drug Chantix can help smokers unwilling or unable to quit abruptly to reduce their smoking before actual quitting. But can a stop-smoking pill that is…
Frank Golhen, via Wikimedia CommonsThe stock gods decided to buy the dip on Tuesday, a day after the biggest sell-off in about three months. Despite a lack of market-moving economic reports, the…
Jon OggWe are now well past the end of 2013, and many strategists have mixed targets for the stock and bond markets in 2014. The last year brought gains of 26.5% in…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, January 10.
With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer and rival Merck & Co.
If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List for years, but 24/7 Wall St. has tracked many major changes to…
